Literature DB >> 3390658

Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.

M P Rivera-Fillat1, J Pallarés-Trujillo, C Domènech, M R Grau-Oliete.   

Abstract

1. The uptake and retention of vincristine (VCR), vinblastine (VBL) and vindesine (VDS) were evaluated comparatively with respect to their cytotoxic action on a murine lymphoblastic leukaemia (L5178Y). 2. The same parameters were measured on a derived subline of cells resistant to VCR (L5178Y/r) in order to determine whether the different degree of resistance to each alkaloid correlates with the amount of drug associated with the cells. 3. VCR was the most active on L5178Y cells (IC50 = 5.8 x 10(-9) M) while the activity of VBL and that of VDS were similar (IC50 4.4 x 10(-8) M and 3.5 x 10(-8) M, respectively). Nevertheless, a considerably larger amount of VBL was taken up by the cells compared to VDS, although there were no significant differences in their cytotoxic action. 4. The VCR resistant cell line also expressed resistance to VDS, whose IC50 was increased by a factor of 11.4, but not to VBL. However, the uptake and retention of the three alkaloids were similarly reduced in L5178Y/r cells regardless of the degree of resistance expressed. 5. Although a decreased drug uptake and/or retention by the cells provides an explanation for the resistance to vinca alkaloids, they do not seem to be the only factors accounting for the resistance shown by the cell line which we have isolated. 6. The results seem to indicate that part of the VBL taken up by the cells is not used to induce the cytotoxic effect, but is diverted to some cellular compartment(s) or rate controlling process(es) which are different from the target that mediates its cytotoxic action.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3390658      PMCID: PMC1853905          DOI: 10.1111/j.1476-5381.1988.tb11478.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Correlation of biologic data with physico-chemical properties among the vinca alkaloids and their congeners.

Authors:  R J Owellen; D W Donigian; C A Hartke; F O Hains
Journal:  Biochem Pharmacol       Date:  1977-07-01       Impact factor: 5.858

Review 2.  DEVELOPMENT, MAINTENANCE AND ASSAY OF DRUG RESISTANCE.

Authors:  G A FISCHER; A C SARTORELLI
Journal:  Methods Med Res       Date:  1964

3.  Pharmacokinetics of vindesine and vincristine in humans.

Authors:  R J Owellen; M A Root; F O Hains
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

4.  Pharmacokinetics and metabolism of vinblastine in humans.

Authors:  R J Owellen; C A Hartke; F O Hains
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

5.  Comparison of the dose- and timesurvival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin.

Authors:  W R Bruce; B E Meeker; W E Powers; F A Valeriote
Journal:  J Natl Cancer Inst       Date:  1969-06       Impact factor: 13.506

6.  Self-assembly of microtubules in extracts of cultured HeLa cells and the identification of HeLa microtubule-associated proteins.

Authors:  J C Bulinski; G G Borisy
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

7.  Measurement of growth and viability of cells in culture.

Authors:  M K Patterson
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

8.  Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.

Authors:  R H Himes; R N Kersey; I Heller-Bettinger; F E Samson
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

Review 9.  Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).

Authors:  R W Dyke; R L Nelson
Journal:  Cancer Treat Rev       Date:  1977-06       Impact factor: 12.111

10.  The distribution of [3H]vinblastine in tumor and host tissues of Nb rats bearting a transplantable lymphoma which is highly sensitive to the alkaloid.

Authors:  R L Noble; P W Gout; L L Wijcik; H F Hebden; C T Beer
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

View more
  3 in total

1.  Relationship between the cellular accumulation and the cytotoxicity of S12363, a new Vinca alkaloid derivative.

Authors:  A Pierré; V Pérez; S Léonce; J A Boutin; D Saint-Dizier; P Hautefaye; G Lavielle; G Atassi
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Interactions of vinblastine and vincristine with methotrexate transport in isolated rat hepatocytes.

Authors:  E Smeland; R M Bremnes; A Bessesen; R Jaeger; J Aarbakke
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.

Authors:  R Pieters; T Hongo; A H Loonen; D R Huismans; H J Broxterman; K Hählen; A J Veerman
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.